People · Operator
Named in public records as an officer, director or promoter · active 2014–2019 · Other Technology, Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NantHealth, Inc. | — | Other Technology | Series D+ | $745.1M | $3.8B | 2014 |
| NantCell, Inc. | — | Other Health Care | Series C | $301.6M | $685.9M | 2015 |
| NantBio, Inc. | — | Biotechnology | Series C | $180.1M | $856.7M | 2014 |
Patrick Shoon-Shiong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Shoon-Shiong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Soon-Shiong | 2 | 16 |
| Charles Kenworthy | 1 | 4 |
| Douglas Reed Maughan | 1 | 3 |
| Michael Blaszyk | 1 | 2 |
| Kirk Calhoun | 1 | 2 |
| Roy Chestnutt | 1 | 2 |
| Deanna Wise | 1 | 1 |
| Ronald Louks | 1 | 1 |
| Brandon Villery | 1 | 1 |
| Vasu Rangadass | 1 | 1 |
| Carlos Cesta | 1 | 1 |
| James Banaag | 1 | 1 |
| Bob Petrou | 1 | 1 |
| Michael Sitrick | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.